<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR73.html">Part 73
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 73.1375  Pyrogallol.
                            </h3>
                            <p class="depth1"><em>(a)</em> Identity. The color additive pyrogallol is 1,2,3- trihydroxybenzene.</p><p class="depth1"><em>(b)</em> Specifications. Pyrogallol shall conform to the following  specifications and shall be free from impurities other than those named  to the extent that such impurities may be avoided by good manufacturing  practice:  Melting point, between 130[deg] and 133 [deg]C. Residue on ignition, not more than 0.1 percent. Lead (as Pb), not more than 20 p/m (parts per million). Arsenic (as As), not more than 3 p/m.</p><p class="depth1"><em>(c)</em> Uses and restrictions. Pyrogallol may be safely used in  combination with ferric ammonium citrate (as listed in Sec. 73.1025),  for coloring plain and chromic catgut sutures for use in general and  ophthalmic surgery, subject to the following restrictions:</p><p class="depth2"><em>(1)</em> The dyed suture shall conform in all respects to the  requirements of the United States Pharmacopeia XX (1980).</p><p class="depth2"><em>(2)</em> The level of the ferric ammonium citrate-pyrogallol complex  shall not exceed 3 percent of the total weight of the suture material.</p><p class="depth2"><em>(3)</em> When the sutures are used for the purposes specified in their  labeling, there is no migration of the color additive to the surrounding  tissues.</p><p class="depth2"><em>(4)</em> If the suture is a new drug, an approved new drug application,  pursuant to section 505 of the act, is in effect for it.</p><p class="depth1"><em>(d)</em> Labeling. The label of the color additive shall conform to the  requirements of Sec. 70.25 of this chapter.</p><p class="depth1"><em>(e)</em> Exemption from certification. Certification of this color  additive is not necessary for the protection of the public health and  therefore batches thereof are exempt from the certification requirements  of section 721(c) of the act.  [42 FR 15643, Mar. 22, 1977, as amended at 49 FR 10089, Mar. 19, 1984]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
